Search for: "DEPOMED, INC" Results 1 - 20 of 25
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Mar 2017, 9:59 pm by Patent Docs
By Donald Zuhn -- Last month, in In re Depomed, Inc., the Federal Circuit affirmed the determination by the U.S. [read post]
19 Jun 2010, 1:19 pm by Mark Zamora
Drug developer Depomed Inc  said it will recall 52 lots of its diabetes drug Glumetza due to the presence of traces of a certain chemical in the tablet's 500 mg bottle.The recall followed an investigation of a single product complaint of a smell and taste consistent with the chemical, the company said in a regulatory filing.The chemical compound, 2,4,6-tribromoanisole (TBA), can cause temporary, non-serious gastrointestinal upset when present in amounts detectable by… [read post]
27 Mar 2016, 9:59 pm by Patent Docs
Depomed, reviewing the decision of the Patent Trial and Appeal Board on three related inter partes reviews. [read post]
21 Jun 2010, 8:19 am
Depomed Inc. has suspended all shipments of the 500 mg product. [read post]
3 Oct 2014, 9:55 pm by Patent Docs
Paul Simboli of Depomed, Inc. will moderate a panel including Patty McDermott of the U.S. [read post]
5 Sep 2017, 5:09 pm by Kevin LaCroix
  Depomed: The first of these investor lawsuits against opioid drug companies was filed on August 18, 2017, when a plaintiff shareholder filed a securities class action lawsuit in the Northern District of California against Depomed, Inc. and three of its current and former officers. [read post]
30 Apr 2018, 8:46 am by Dennis Crouch
Andrei Iancu, No. 16-1526 Depomed, Inc. v. [read post]
16 Jun 2017, 6:02 am by Lawrence B. Ebert
Aeroquip Corp., 713 F.2d 1530, 1538 (Fed.Cir. 1983); In re Depomed, Inc., No. 2016-1378, 2017 WL676604, at *5 (Fed. [read post]